logo
logo

Insilico Medicine, Inc. announced it raised $6 Million in an initial filing from an offering of $6 Million

Insilico Medicine, Inc. announced it raised $6 Million in an initial filing from an offering of $6 Million

06/18/18, 3:34 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgcambridge
Money raised
$6 million
Industry
biotechnology

Company Info

Company
Insilico Medicine
Location
1000 massachusetts avenue, suite 126
cambridge, massachusetts, united states
Additional Info
Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.

Related People